142 related articles for article (PubMed ID: 19763026)
1. Thallium-201 chloride scintigraphy in soft tissue tumors.
Otsuka H; Terazawa K; Morita N; Otomi Y; Takao S; Iwamoto S; Osaki K; Harada M; Nishitani H
J Med Invest; 2009 Aug; 56(3-4):136-41. PubMed ID: 19763026
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of TI-201 and three-phase bone scintigraphy for bone and soft-tissue tumors.
Nishiyama Y; Yamamoto Y; Toyama Y; Satoh K; Ohkawa M; Tanabe M
Clin Nucl Med; 2000 Mar; 25(3):200-5. PubMed ID: 10698418
[TBL] [Abstract][Full Text] [Related]
3. Thallium-201 scintigraphy in bone and soft-tissue tumors: a comparison of dynamic, early and delayed scans.
Sugawara Y; Kikuchi T; Kajihara M; Semba T; Ochi T; Fujii T; Mochizuki T; Sakayama K; Nakata S
Ann Nucl Med; 2005 Sep; 19(6):461-8. PubMed ID: 16248382
[TBL] [Abstract][Full Text] [Related]
4. Thallium-201 scintigraphy is an effective diagnostic modality to distinguish malignant from benign soft-tissue tumors.
Kawakami N; Kunisada T; Sato S; Morimoto Y; Tanaka M; Sasaki T; Sugihara S; Yanai H; Kanazawa S; Ozaki T
Clin Nucl Med; 2011 Nov; 36(11):982-6. PubMed ID: 21975384
[TBL] [Abstract][Full Text] [Related]
5. [Clinical usefulness of thallium-201 chloride in the diagnosis of tumor (II)--An evaluation in bone, soft tissue and mediastinal tumors].
Tonami N; Itoh K; Yui N; Terui S; Torizuka K
Kaku Igaku; 1994 Jan; 31(1):63-74. PubMed ID: 8309112
[TBL] [Abstract][Full Text] [Related]
6. Correlations between F-18 FDG PET/CT and pathological findings in soft tissue lesions.
Nose H; Otsuka H; Otomi Y; Terazawa K; Takao S; Iwamoto S; Harada M
J Med Invest; 2013; 60(3-4):184-90. PubMed ID: 24190034
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Tc-99m pertechnetate with Tl-201 and Ga-67 scintigraphy of malignant soft-tissue tumors.
Abe H; Terui S; Terauchi T; Muramatsu Y; Yokayama R; Ohtomo K; Beppu Y; Fukuma H
Clin Nucl Med; 1997 Jan; 22(1):38-41. PubMed ID: 8993872
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of F-18 FDG PET and 201Tl scintigraphy for detection of primary malignant bone and soft-tissue tumors.
Yamamoto Y; Kawaguchi Y; Kawase Y; Maeda Y; Nishiyama Y
Clin Nucl Med; 2011 Apr; 36(4):290-4. PubMed ID: 21368603
[TBL] [Abstract][Full Text] [Related]
9. Dynamic scintigraphy with thallium-201 chloride (Tl-201) for the diagnosis of tumors of the head and neck.
Sato T; Indo H; Kawabata Y; Iwashita Y; Morita Y; Noikura T; Sugihara K; Mimura T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):228-35. PubMed ID: 11505272
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of thallium-201 scintigraphy in bone and soft tissue tumors.
Goto Y; Ihara K; Kawauchi S; Ohi R; Sasaki K; Kawai S
J Orthop Sci; 2002; 7(3):304-12. PubMed ID: 12077654
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of Thallium-201 scintigraphy in differentiating malignant bone tumors from benign bone lesions.
Inai R; Shinya T; Tada A; Sato S; Fujiwara T; Takeda K; Kunisada T; Yanai H; Ozaki T; Kanazawa S
Ann Nucl Med; 2015 Oct; 29(8):674-81. PubMed ID: 26036991
[TBL] [Abstract][Full Text] [Related]
12. On clinical usefulness of Tl-201 scintigraphy for the management of malignant soft tissue tumors.
Terui S; Terauchi T; Abe H; Fukuma H; Beppu Y; Chuman K; Yokoyama R
Ann Nucl Med; 1994 Feb; 8(1):55-64. PubMed ID: 8204398
[TBL] [Abstract][Full Text] [Related]
13. [Quantitative assessment of 201Tl-SPECT in tumors of bone and soft tissue].
Matsui R; Komori T; Nakata Y; Doi K; Tabuchi K; Saika Y; Utsunomiya K; Adachi I; Shimizu T; Sueyoshi K; Narabayashi I; Morishita S
Kaku Igaku; 1999 Apr; 36(3):219-28. PubMed ID: 10358956
[TBL] [Abstract][Full Text] [Related]
14. Value of thallium-201 scintigraphy in bone and soft tissue tumors.
Sato O; Kawai A; Ozaki T; Kunisada T; Danura T; Inoue H
J Orthop Sci; 1998; 3(6):297-303. PubMed ID: 9811980
[TBL] [Abstract][Full Text] [Related]
15. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
16. MRI of soft-tissue masses: the relationship between lesion size, depth, and diagnosis.
Datir A; James SL; Ali K; Lee J; Ahmad M; Saifuddin A
Clin Radiol; 2008 Apr; 63(4):373-8; discussion 379-80. PubMed ID: 18325355
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of delayed 18F-FDG PET in differential diagnosis for malignant soft-tissue tumors.
Hamada K; Tomita Y; Ueda T; Enomoto K; Kakunaga S; Myoui A; Higuchi I; Yoshikawa H; Hatazawa J
Ann Nucl Med; 2006 Dec; 20(10):671-5. PubMed ID: 17385305
[TBL] [Abstract][Full Text] [Related]
18. [Initial trial of tumor imaging using 123I-BMIPP: evaluation in soft tissue tumors].
Tanabe Y; Suto Y; Ohta Y
Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Nov; 56(13):982-4. PubMed ID: 8969064
[TBL] [Abstract][Full Text] [Related]
19. Evaluating benign and malignant bone and soft-tissue lesions with technetium-99m-MIBI scintigraphy.
Taki J; Sumiya H; Tsuchiya H; Tomita K; Nonomura A; Tonami N
J Nucl Med; 1997 Apr; 38(4):501-6. PubMed ID: 9098190
[TBL] [Abstract][Full Text] [Related]
20. A comparative study of 201Tl scintigraphy and three-phase bone scintigraphy following therapy in patients with bone and soft-tissue tumors.
Nishiyama Y; Yamamoto Y; Yokoe K; Kawaguchi Y; Toyama Y; Satoh K; Ohkawa M
Ann Nucl Med; 2004 May; 18(3):235-41. PubMed ID: 15233285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
